MedPath

Nystatin

NYSTATIN ORAL SUSPENSION, USP

Approved
Approval ID

8d3531b9-13b4-471b-8315-9d05c80208f6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 31, 2025

Manufacturers
FDA

ATLANTIC BIOLOGICALS CORP.

DUNS: 047437707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nystatin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17856-0538
Application NumberANDA062512
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nystatin
Product Specifications
Route of AdministrationORAL
Effective DateJuly 31, 2025
FDA Product Classification

INGREDIENTS (24)

glycerinInactive
Code: PDC6A3C0OX
Classification: IACT
potassium phosphate, dibasicInactive
Code: CI71S98N1Z
Classification: IACT
alcoholInactive
Code: 3K9958V90M
Classification: IACT
NystatinActive
Quantity: 100000 [USP'U] in 1 mL
Code: BDF1O1C72E
Classification: ACTIB
waterInactive
Code: 059QF0KO0R
Classification: IACT
magnesium aluminum silicateInactive
Code: 6M3P64V0NC
Classification: IACT
sucroseInactive
Code: C151H8M554
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
methylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
propylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
FD&C red no. 40Inactive
Code: WZB9127XOA
Classification: IACT
D&C yellow no. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NC
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
POTASSIUM PHOSPHATE, DIBASICInactive
Code: CI71S98N1Z
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
NYSTATINActive
Quantity: 100000 [USP'U] in 1 mL
Code: BDF1O1C72E
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 5/21/2024

PRINCIPAL DISPLAY PANEL - 60 mL Bottle Carton

NYSTATIN ORAL

SUSPENSION, USP
(100,000 units
per mL)

Fruit Flavored

Rx Only

image description

image description

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 10/16/2017

ADVERSE REACTIONS

Nystatin is well tolerated even with prolonged therapy. Oral irritation and sensitization have been reported. (SeePRECAUTIONS: General).

Gastrointestinal:Diarrhea (including one case of bloody diarrhea), nausea, vomiting, gastrointestinal upset/disturbances.

Dermatologic:Rash, including urticaria has been reported rarely. Stevens- Johnson syndrome has been reported very rarely.

Other:Tachycardia, bronchospasm, facial swelling, and non-specific myalgia have also been rarely reported.

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 10/16/2017

CLINICAL PHARMACOLOGY

Pharmacokinetics

Gastrointestinal absorption of nystatin is insignificant. Most orally administered nystatin is passed unchanged in the stool. In patients with renal insufficiency receiving oral therapy with conventional dosage forms, significant plasma concentrations of nystatin may occasionally occur.

Microbiology

Nystatin is both fungistatic and fungicidal in vitroagainst a wide variety of yeasts and yeast-like fungi. Candida albicansdemonstrates no significant resistance to nystatin in vitroon repeated subculture in increasing levels of nystatin; other Candidaspecies become quite resistant. Generally, resistance does not develop in vivo. Nystatin acts by binding to sterols in the cell membrane of susceptible Candidaspecies with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 10/16/2017

Rx Only

Product No.: 8537

Manufactured For:
** Wockhardt USA, LLC**
** Parsippany, NJ 07054**

Manufactured By:
** Morton Grove Pharmaceuticals, Inc.**
** Morton Grove, IL 60053**

28537B
REV. 09-09

​Distributed by Atlantic Biologicals

​Miami, Fl 33179

DESCRIPTION SECTION

LOINC: 34089-3Updated: 10/17/2017

DESCRIPTION

Nystatin is an antimycotic polyene antibiotic obtained from Streptomyces noursei. Structural formula:

image description

Nystatin Oral Suspension, for oral administration, contains 100,000 USP Nystatin Units per mL. Inactive ingredients: alcohol (≤ 1% v/v), artificial wild cherry flavor, banana flavor, D&C yellow #10, FD&C red #40, glycerin, USP, magnesium aluminum silicate, methylparaben, NF, potassium phosphate dibasic, USP, propylene glycol, USP, propylparaben, NF, purified water, USP and sucrose 33.5%. May also contain citric acid, USP for pH adjustment.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nystatin - FDA Drug Approval Details